Fexofenadine Hydrochloride
Product Images NDC 0904-6711

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride (NDC 0904-6711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle (Bottle)

Fexofenadine hydrochloride 180 mg tablets by MAJOR PHARMACEUTICALS, NDC 0904-6711, packaged as 30 non-drowsy tablets for indoor and outdoor allergies. The label includes drug facts, warnings, dosing directions for adults and children 12 years and older, and storage instructions. The packaging is predominantly purple and yellow with bold text highlighting the active ingredient and allergy relief purpose.*

FDA Label Image

Carton (Carton)

Packaging label for Fexofenadine hydrochloride tablets USP, 180 mg, an antihistamine by MAJOR PHARMACEUTICALS. The label shows a box and bottle containing 30 tablets each of 180 mg strength. The label highlights 24-hour allergy relief with indications for indoor and outdoor allergies, and symptoms like sneezing, runny nose, itchy/watery eyes, and itchy nose or throat. The label also notes that the product is non-drowsy.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.